TELVAS H 40/12.5 (Telmisartan (40mg) + Hydrochlorothiazide (12.5mg))

Telvas H 40/12.5 Tablet combines two active ingredients to assist in managing elevated blood pressure levels. This medication is typically prescribed when monotherapy does not adequately lower blood pressure. Effectively reducing high blood pressure is crucial as it contributes to minimizing the likelihood of serious cardiovascular events such as heart attacks or strokes. The tablet can be taken with or without meals, and the specific dosage will be determined based on individual health conditions and response to treatment. It is advisable to take the medication consistently at the same time each day. Adhering to the treatment regimen is important, even if symptoms improve, as high blood pressure can often be asymptomatic. Due to the diuretic component of this medication, it may increase urine output; therefore, it is generally recommended to avoid taking it in the hours leading up to bedtime. Regular use is essential to achieve optimal benefits from the medication. Patients should be aware that stopping the medication without medical advice can elevate the risk of cardiovascular issues. While dizziness is a commonly reported side effect, others may include fatigue, nausea, shortness of breath, and irregular heartbeats. Increased urination is an intended effect of the medication, not a side effect. It is important to review the informational leaflet provided with the medication and communicate with a healthcare provider regarding any ongoing or concerning side effects for potential dosage adjustments or alternative treatments. Additionally, avoid potassium supplements and salt substitutes unless directed by a doctor. This medication is generally contraindicated during pregnancy and breastfeeding. Prior consultation is essential if there are pre-existing conditions such as kidney or liver disease, heart issues, or diabetes. Consumption of alcohol may further reduce blood pressure and increase side effects.